Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Syngeneic Stem Cell Transplantation

A procedure in which a patient receives blood-forming stem cells (cells from which all blood cells develop) donated by his or her healthy identical… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Stem cell transplantation; Iranian experience.
From March 1991 through 31st December 2007, 2042 patients underwent stem cell transplantation at the Hematology-Oncology and Stem… Expand
  • figure 1
  • figure 3
  • figure 2
2009
2009
Plasma cell leukemia maintaining complete remission by syngeneic stem cell transplantation combined with low-dose thalidomide maintenance therapy.
Plasma cell leukemia (PCL) is a rare variant of multiple myeloma, which is very aggressive and resistant to chemotherapy. We… Expand
  • figure 1
2005
2005
High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial…
BACKGROUND Immunoablative therapy combined with haematopoietic stem cell transplantation (SCT) is a possible treatment for… Expand
  • figure 1
  • figure 2
2004
2004
Autologous/syngeneic stem cell transplantation to treat refractory GvHD
Summary:Severe graft-versus-host disease (GvHD) refractory to corticosteroids responds poorly to experimental treatment and is… Expand
2004
2004
Suppressing immunity in advancing MS
Although no direct evidence exists that the immune system per se initiates the attack on myelin in patients with multiple… Expand
Highly Cited
2002
Highly Cited
2002
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation
We assessed long-term outcome in 155 patients who had undergone an allogeneic/syngeneic stem cell transplant (SCT) and were in… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 4
2002
2002
Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice
Dendritic cell (DC) vaccination represents an interesting immunotherapeutic option in the treatment of several malignancies. In… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
1998
1998
Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemia
Abstract Allogeneic bone marrow transplantation is the only curative treatment for patients with Philadelphia chromosome-positive… Expand
  • figure 1
  • figure 2
  • table 1
1997
1997
Differential short‐term and long‐term repopulating ability of stem cell subsets in mice
Hematopoietic reconsitution after transplantation requires the presence of cells with early and late repopulating ability. To… Expand
1993
1993
Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT.
  • S. Slavin
  • Bone marrow transplantation
  • 1993
    • Corpus ID: 39084367
We describe a case of autoimmune-mediated mixed cryoglobulinemia with vasculitis and nephritis that was successfully treated with… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE